Last reviewed · How we verify
NCT04030832: MG-1
Reconstruction of Skin Substance Loss With "Micro-grafts" Obtained by Mechanical Disintegration
trial in Cutaneous Ulcer in 70 participants. Completed in 30 June 2019.
1 October 2018
Quick facts
| Lead sponsor | Azienda Ospedaliero, Universitaria Ospedali Riuniti |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 70 |
| Start date | 1 October 2017 |
| Primary completion | 1 October 2018 |
| Estimated completion | 30 June 2019 |
| Sites | 4 locations across Italy |
Conditions studied
- Cutaneous Ulcer — all drugs for Cutaneous Ulcer →
- Trauma Injury — all drugs for Trauma Injury →
Sponsor
Azienda Ospedaliero, Universitaria Ospedali Riuniti
Who can join
Adults 18 to 70, any sex, with Cutaneous Ulcer or Trauma Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The etiology of non-healing ulcers depends on both systemic and local factors. The introduction of advanced dressing, negative wound therapy and compression therapy have undoubtedly improved clinical outcomes. The principal aim of study was to demonstrate the efficacy of skin micrografts in the treatment of skin substance loss.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A Multicentre Study: The Use of Micrografts in the Reconstruction of Full-Thickness Posttraumatic Skin Defects of the Limbs-A Whole Innovative Concept in Regenerative Surgery.
Riccio M, Marchesini A, Zingaretti N, Carella S, et al · · 2019 · cited 32× · PMID 31885613 · DOI 10.1155/2019/5043518 -
Tissue regeneration: an overview from stem cells to micrografts.
Astarita C, Arora CL, Trovato L. · · 2020 · cited 18× · PMID 32536230 · DOI 10.1177/0300060520914794
Verify or expand the search:
- PubMed search for NCT04030832
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Azienda Ospedaliero, Universitaria Ospedali Riuniti trials
Trials by the same sponsor.
- NCT07086144 — Efficacy of a Myocardial Panel in the Management and Treatment of Pediatric Myocarditis · NA · recruiting
- NCT06993467 — Oxygen Delivery During Cardiopulmonary Bypass And Inflammatory Reaction After Cardiac Surgery · completed
- NCT06371170 — Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population · recruiting
- NCT06997991 — Prospective Clinical Study to Evaluate the Safety and Efficacy of Intraarticular Administration of Micro-grafts of Adipo · NA · completed
- NCT06071156 — Therapy Management in Patients Treated With Anakinra Due to Recurrent Pericarditis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04030832 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero, Universitaria Ospedali Riuniti
- Last refreshed: 24 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04030832.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing